vs
COMMVAULT SYSTEMS INC（CVLT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
COMMVAULT SYSTEMS INC的季度营收约是Orthofix Medical Inc.的1.4倍（$311.7M vs $219.9M），COMMVAULT SYSTEMS INC净利率更高（4.7% vs -1.0%，领先5.7%），COMMVAULT SYSTEMS INC同比增速更快（13.3% vs 2.0%），COMMVAULT SYSTEMS INC自由现金流更多（$131.8M vs $16.8M），过去两年COMMVAULT SYSTEMS INC的营收复合增速更高（17.8% vs 8.0%）
Commvault Systems Inc.是美国上市的网络安全与数据保护软件企业，核心业务覆盖数据安全、云服务及基础设施管理领域，旗下方案广泛应用于各类企业的数据资产防护与IT架构运维场景，助力客户降低数据风险、提升云环境运营效率。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CVLT vs OFIX — 直观对比
营收规模更大
CVLT
是对方的1.4倍
$219.9M
营收增速更快
CVLT
高出11.4%
2.0%
净利率更高
CVLT
高出5.7%
-1.0%
自由现金流更多
CVLT
多$115.0M
$16.8M
两年增速更快
CVLT
近两年复合增速
8.0%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $311.7M | $219.9M |
| 净利润 | $14.6M | $-2.2M |
| 毛利率 | 81.4% | 71.1% |
| 营业利润率 | 5.3% | 0.2% |
| 净利率 | 4.7% | -1.0% |
| 营收同比 | 13.3% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.34 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVLTOFIX
| Q1 26 | $311.7M | — | ||
| Q4 25 | $313.8M | $219.9M | ||
| Q3 25 | $276.2M | $205.6M | ||
| Q2 25 | $282.0M | $203.1M | ||
| Q1 25 | $275.0M | $193.6M | ||
| Q4 24 | $262.6M | $215.7M | ||
| Q3 24 | $233.3M | $196.6M | ||
| Q2 24 | $224.7M | $198.6M |
净利润CVLTOFIX
| Q1 26 | $14.6M | — | ||
| Q4 25 | $17.8M | $-2.2M | ||
| Q3 25 | $14.7M | $-22.8M | ||
| Q2 25 | $23.5M | $-14.1M | ||
| Q1 25 | $31.0M | $-53.1M | ||
| Q4 24 | $11.0M | $-29.1M | ||
| Q3 24 | $15.6M | $-27.4M | ||
| Q2 24 | $18.5M | $-33.4M |
毛利率CVLTOFIX
| Q1 26 | 81.4% | — | ||
| Q4 25 | 81.1% | 71.1% | ||
| Q3 25 | 80.1% | 72.2% | ||
| Q2 25 | 82.0% | 68.7% | ||
| Q1 25 | 82.6% | 62.8% | ||
| Q4 24 | 81.5% | 69.0% | ||
| Q3 24 | 81.6% | 68.7% | ||
| Q2 24 | 82.3% | 67.8% |
营业利润率CVLTOFIX
| Q1 26 | 5.3% | — | ||
| Q4 25 | 6.3% | 0.2% | ||
| Q3 25 | 4.5% | -8.3% | ||
| Q2 25 | 8.9% | -7.9% | ||
| Q1 25 | 9.7% | -25.2% | ||
| Q4 24 | 5.2% | -5.3% | ||
| Q3 24 | 6.4% | -9.6% | ||
| Q2 24 | 8.2% | -12.5% |
净利率CVLTOFIX
| Q1 26 | 4.7% | — | ||
| Q4 25 | 5.7% | -1.0% | ||
| Q3 25 | 5.3% | -11.1% | ||
| Q2 25 | 8.3% | -6.9% | ||
| Q1 25 | 11.3% | -27.4% | ||
| Q4 24 | 4.2% | -13.5% | ||
| Q3 24 | 6.7% | -13.9% | ||
| Q2 24 | 8.2% | -16.8% |
每股收益（稀释后）CVLTOFIX
| Q1 26 | $0.34 | — | ||
| Q4 25 | $0.40 | $-0.05 | ||
| Q3 25 | $0.33 | $-0.57 | ||
| Q2 25 | $0.52 | $-0.36 | ||
| Q1 25 | $0.68 | $-1.35 | ||
| Q4 24 | $0.24 | $-0.76 | ||
| Q3 24 | $0.35 | $-0.71 | ||
| Q2 24 | $0.41 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $900.0M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.5M | $450.0M |
| 总资产 | $1.9B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVLTOFIX
| Q1 26 | $900.0M | — | ||
| Q4 25 | $1.0B | $82.0M | ||
| Q3 25 | $1.1B | $62.9M | ||
| Q2 25 | $363.2M | $65.6M | ||
| Q1 25 | $302.1M | $58.0M | ||
| Q4 24 | $243.6M | $83.2M | ||
| Q3 24 | $303.1M | $30.1M | ||
| Q2 24 | $287.9M | $26.4M |
总债务CVLTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M |
股东权益CVLTOFIX
| Q1 26 | $7.5M | — | ||
| Q4 25 | $216.7M | $450.0M | ||
| Q3 25 | $210.5M | $442.5M | ||
| Q2 25 | $364.7M | $458.3M | ||
| Q1 25 | $325.1M | $458.3M | ||
| Q4 24 | $287.8M | $503.1M | ||
| Q3 24 | $277.8M | $525.9M | ||
| Q2 24 | $281.8M | $546.0M |
总资产CVLTOFIX
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.0B | $850.6M | ||
| Q3 25 | $1.9B | $832.6M | ||
| Q2 25 | $1.2B | $837.2M | ||
| Q1 25 | $1.1B | $823.1M | ||
| Q4 24 | $1.0B | $893.3M | ||
| Q3 24 | $958.5M | $867.9M | ||
| Q2 24 | $934.9M | $882.0M |
负债/权益比CVLTOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $132.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $131.8M | $16.8M |
| 自由现金流率自由现金流/营收 | 42.3% | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 9.02× | — |
| 过去12个月自由现金流最近4个季度 | $237.2M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CVLTOFIX
| Q1 26 | $132.2M | — | ||
| Q4 25 | $4.0M | $27.7M | ||
| Q3 25 | $76.8M | $12.4M | ||
| Q2 25 | $31.7M | $11.6M | ||
| Q1 25 | $77.0M | $-18.4M | ||
| Q4 24 | $30.1M | $23.7M | ||
| Q3 24 | $55.6M | $11.7M | ||
| Q2 24 | $44.7M | $9.0M |
自由现金流CVLTOFIX
| Q1 26 | $131.8M | — | ||
| Q4 25 | $1.9M | $16.8M | ||
| Q3 25 | $73.6M | $2.5M | ||
| Q2 25 | $29.8M | $4.5M | ||
| Q1 25 | $76.2M | $-25.1M | ||
| Q4 24 | $29.9M | $15.2M | ||
| Q3 24 | $53.7M | $6.3M | ||
| Q2 24 | $43.8M | $-360.0K |
自由现金流率CVLTOFIX
| Q1 26 | 42.3% | — | ||
| Q4 25 | 0.6% | 7.6% | ||
| Q3 25 | 26.6% | 1.2% | ||
| Q2 25 | 10.6% | 2.2% | ||
| Q1 25 | 27.7% | -13.0% | ||
| Q4 24 | 11.4% | 7.0% | ||
| Q3 24 | 23.0% | 3.2% | ||
| Q2 24 | 19.5% | -0.2% |
资本支出强度CVLTOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 4.9% | ||
| Q3 25 | 1.2% | 4.8% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | 0.1% | 4.0% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | 0.4% | 4.7% |
现金转化率CVLTOFIX
| Q1 26 | 9.02× | — | ||
| Q4 25 | 0.23× | — | ||
| Q3 25 | 5.21× | — | ||
| Q2 25 | 1.35× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | 2.74× | — | ||
| Q3 24 | 3.57× | — | ||
| Q2 24 | 2.41× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVLT
| Term-based license | $114.4M | 37% |
| Software-as-a-service | $93.1M | 30% |
| Customer support | $80.9M | 26% |
| Other | $13.1M | 4% |
| Perpetual license | $10.1M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
